Radioiodine based biomedical carriers for cancer theranostics
J Guo, H Xiong, H Liu, T Zhang, X Sun - Coordination Chemistry Reviews, 2023 - Elsevier
Theranostics, a promising modern concept combining diagnostic capabilities and
therapeutic effects, has been used for optimizing and personalizing the treatment of many …
therapeutic effects, has been used for optimizing and personalizing the treatment of many …
Efficacy and safety of 124I-MIBG dosimetry-guided high-activity 131I-MIBG therapy of advanced pheochromocytoma or neuroblastoma
I Maric, M Weber, A Prochnow, J Schmitz… - Journal of Nuclear …, 2023 - Soc Nuclear Med
We aim to evaluate the efficacy and safety of 124I-metaiodobenzylguanidine (MIBG)
dosimetry-guided high-activity 131I-MIBG therapy of advanced pheochromocytoma or …
dosimetry-guided high-activity 131I-MIBG therapy of advanced pheochromocytoma or …
Adrenal functional imaging–which marker for which indication?
RA Werner, PE Hartrampf, A Schirbel… - Current Opinion in …, 2022 - journals.lww.com
Adrenal functional imaging – which marker for which indicati... : Current Opinion in Urology
Adrenal functional imaging – which marker for which indication? : Current Opinion in Urology …
Adrenal functional imaging – which marker for which indication? : Current Opinion in Urology …
[HTML][HTML] Biodistribution and radiation dosimetry of 124I-mIBG in adult patients with neural crest tumours and extrapolation to paediatric models
A Moraitis, W Jentzen, G Reiter, J Schmitz, TD Pöppel… - EJNMMI physics, 2024 - Springer
Aim Positron emission tomography (PET) using 124I-mIBG has been established for
imaging and pretherapeutic dosimetry. Here, we report the first systematic analysis of the …
imaging and pretherapeutic dosimetry. Here, we report the first systematic analysis of the …
Predictive factors of early FDG-PET response to [131I] MIBG treatment for unresectable or metastatic pheochromocytomas and paragangliomas (PPGLs)
J Takenaka, S Watanabe, T Abe, T Tsuchikawa… - …, 2023 - karger.com
Methods A retrospective study was performed on a series of 20 patients who underwent
FDG-PET before and after [131I] MIBG therapy. We administered a single dose comprising …
FDG-PET before and after [131I] MIBG therapy. We administered a single dose comprising …
MIBG Uptake in a Gastric Gastrointestinal Stromal Tumor
K Zheng, H Jing, Y Liu, F Li - Clinical Nuclear Medicine, 2022 - journals.lww.com
MIBG scintigraphy is the imaging choice in the evaluation of pheochromocytoma and
neuroblastoma. 131 I-MIBG uptake by gastrointestinal stromal tumors was rare. Here we …
neuroblastoma. 131 I-MIBG uptake by gastrointestinal stromal tumors was rare. Here we …
Junki Takenakaa, b Shiro Watanabea, b, c Takashige Abed Takahiro Tsuchikawae, f Satoshi Takeuchif, g Kenji Hirataa, b, c, f, h
R Kimuraa, N Wakabayashia, N Shinoharad, K Kudoa - 2023 - karger.com
Abstract Introduction: Pheochromocytomas and paragangliomas (PPGLs) are rare
neuroendocrine tumours that produce catecholamines.[131I] metaiodobenzylguanidine …
neuroendocrine tumours that produce catecholamines.[131I] metaiodobenzylguanidine …
Development and Prospect of Theranostic Medical Isotopes and Radiopharmaceuticals in China
C Yue - 协和医学杂志, 2022 - xhyxzz.pumch.cn
Theranostics in nuclear medicine is the combination of radionuclide imaging and internal
radiotherapy, so as to realize the visualized diagnosis and precise treatment of diseases. At …
radiotherapy, so as to realize the visualized diagnosis and precise treatment of diseases. At …
Imaging of Pheochromocytomas and Paragangliomas
HJLM Timmers, D Taïeb, K Pacak… - Endocrine …, 2024 - academic.oup.com
Pheochromocytomas/paragangliomas are unique in their highly variable molecular
landscape driven by genetic alterations, either germline or somatic. These mutations …
landscape driven by genetic alterations, either germline or somatic. These mutations …
我国诊疗一体化核素及放射性药物临床应用与展望
陈跃 - 协和医学杂志, 2022 - xhyxzz.pumch.cn
核医学诊疗一体化是将放射性核素显像与内放射治疗相结合, 从而实现疾病的可视化诊断和精准
治疗. 目前, 核医学诊疗一体化已在分化型甲状腺癌, 嗜铬细胞瘤, 恶性肿瘤骨转移 …
治疗. 目前, 核医学诊疗一体化已在分化型甲状腺癌, 嗜铬细胞瘤, 恶性肿瘤骨转移 …